This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Charlotta Ljungqvist: Innovator in Biopharmaceuticals
Introduction
Charlotta Ljungqvist is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on receptor structures.
Latest Patents
Charlotta holds 1 patent related to modified polypeptide derivatives of the B domain or Z domain of staphylococcal protein A (SPA). His invention focuses on derivatives that contain amino acid substitutions, allowing the B domain or Z domain to interact with at least one domain of a human Factor VIII protein. This interaction occurs without substantially disrupting the structure and stability of the B domain or Z domain.
Career Highlights
Charlotta is currently associated with Biovitrum AB, a company known for its advancements in biopharmaceuticals. His work has been instrumental in developing therapies that can improve patient outcomes in various medical conditions.
Collaborations
Charlotta has collaborated with notable colleagues, including Karin Nord and Per-Åke Nygren, to further enhance the impact of his research and innovations.
Conclusion
Charlotta Ljungqvist's contributions to the field of biopharmaceuticals exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile